Product Information
NEUPOGEN 300 MCG/ML VIAL is a brand product labeled by Amgen Inc., priced at $304.0908 per ML under NDC 55513053010. Its NADAC has been published 261 times since Nov 28, 2013.
Strength
300 ug/mL
Manufacturer
Amgen Inc.NDC
55513053010
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
FILGRASTIMApproval Type
Biologic (BLA)
FDA Application
BLA103353On Market Since
5/19/1997
Pharmacological Classes
Price Statistics
The NADAC for NEUPOGEN 300 MCG/ML VIAL has been published 261 times since Nov 28, 2013, and over the history we have for it it has risen 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $304.0908 per ML |
|---|---|
| All-time high | $306.6472 (Jan 14, 2026) |
| All-time low | $278.5910 (Jun 18, 2014) |
| 52-week high | $306.6472 |
| 52-week low | $303.7760 |
| Median price | $291.3080 |
| Average price | $295.7294 |
| Largest weekly change | +4.6% (Apr 17, 2024) |
| Weeks tracked | 261 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NEUPOGEN 300 MCG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for NEUPOGEN 300 MCG/ML VIAL, manufactured by Amgen Inc., is $304.0908 per ML (NDC 55513053010), effective Aug 19, 2026.
How has the price of NEUPOGEN 300 MCG/ML VIAL changed over time?
Over the history we have for it, the NADAC for NEUPOGEN 300 MCG/ML VIAL has risen 6.6%. It has been tracked across 261 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEUPOGEN 300 MCG/ML VIAL?
Since Nov 28, 2013, the NADAC for NEUPOGEN 300 MCG/ML VIAL has ranged from a low of $278.5910 (Jun 18, 2014) to a high of $306.6472 (Jan 14, 2026), with a median of $291.3080 per ML.
Are there cheaper alternatives to NEUPOGEN 300 MCG/ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NEUPOGEN 300 MCG/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures NEUPOGEN 300 MCG/ML VIAL?
NEUPOGEN 300 MCG/ML VIAL (NDC 55513053010) is labeled by Amgen Inc., and CMS classifies it as a brand product.